Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2099.14 | 1576.00 | 10970.00 | 0.1437 | -0.1132 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2099.14 | 10560.00 | 10970.00 | 0.9626 | 0.9683 |
| MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 11484.00 | 10970.00 | 1.0469 | 1.0388 | |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2099.14 | 2754.00 | 10970.00 | 0.2511 | 0.1206 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2099.14 | 10410.00 | 10970.00 | 0.9490 | 0.9566 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2099.14 | 10555.00 | 10970.00 | 0.9622 | 0.9679 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2099.14 | 7325.00 | 10970.00 | 0.6677 | 0.6885 |
| MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 11136.00 | 10970.00 | 1.0151 | 1.0126 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 99.00 | 112.50 | 0.8800 | 0.2762 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 149.00 | 112.50 | 1.3244 | 4.3694 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 120.00 | 112.50 | 1.0667 | 1.5092 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 156.25 | 92.36 | 106.00 | 112.50 | 0.9422 | 0.6225 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 92.36 | 80.00 | 112.50 | 0.7111 | -0.3965 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 62.00 | 112.50 | 0.5511 | -0.7536 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 246.00 | 112.50 | 2.1867 | 30.2771 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 156.25 | 92.36 | 90.00 | 112.50 | 0.8000 | -0.0871 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 92.36 | 121.00 | 112.50 | 1.0756 | 1.5835 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 116.00 | 112.50 | 1.0311 | 1.2274 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 156.25 | 92.36 | 66.00 | 112.50 | 0.5867 | -0.6931 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 156.25 | 92.36 | 157.00 | 112.50 | 1.3956 | 5.4529 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 95.00 | 112.50 | 0.8444 | 0.1040 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 95.00 | 112.50 | 0.8444 | 0.1040 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 156.25 | 92.36 | 84.00 | 112.50 | 0.7467 | -0.2837 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 93.00 | 112.50 | 0.8267 | 0.0244 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 110.00 | 112.50 | 0.9778 | 0.8481 |